Capital Royalty Group is a global healthcare investor that has operated across the globe since 2003.
Investing capital debt and equity structures in collaborative partnerships to focus on minimized dilution and strong value-added support for companies has been a consistent role for Capital Royalty Group. The firm is interested in companies such as Harmony Biosciences, HNI Healthcare, Earlens Corporation, EndoGastric Solutions, Synergy Pharmaceuticals, Stonebridge Biopharma, and Silk Road Medical.
EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Silk Road Medical is a Sunnyvale, California-based healthcare company.